EUVIMEDEUVIMED entdecken
Open Access

Inflammatory Biomarkers in Smokers: Implications for Ligamentum Flavum Hypertrophy

Eyüp Çetin, Dilara Başgül Sagiri, Eylem Burcu Kahraman Özlü, Ezgi Akar, Eray Metin Güler iD, Sarper Kocaoğlu, Hakan Beyaztaş, Emine Demir

Medical Science Monitor · 2025

DOI: 10.12659/msm.947508 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Medical Science Monitor, 2025. Verfasst von Eyüp Çetin und 7 weiteren Autor:innen. Beteiligte Einrichtung: Neurosurgery Clınıc, Health Sciences University Haydarpaşa Training and Research Hospital, Istanbul, Turkey. Hauptthemen laut MEDLINE: Ligamentum Flavum, Smoking. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND Ligamentum flavum (LF) hypertrophy is a key contributor to spinal pathologies such as lumbar and cervical disc herniations and spinal stenosis. Smoking, as a modifiable lifestyle factor, is implicated in systemic inflammation and oxidative stress, potentially exacerbating LF hypertrophy. This study aimed to compare the expression of alpha-1 antitrypsin (AAT), interleukin-1 beta (IL-1 beta), interleukin-6 (IL-6), and tumor necrosis factor-alpha (TNF-alpha) in the lumbar ligamentum flavum from 27 smokers and 31 non-smokers. MATERIAL AND METHODS LF tissue samples were collected during spinal surgeries. Demographic, anthropometric, and clinical data were recorded. ELISA was used to quantify levels of AAT, IL-1ß, IL-6, and TNF-alpha. Statistical analyses included t-tests, Mann-Whitney U tests, and receiver operating characteristic (ROC) curve analyses. Statistical significance was set at p

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ligamentum FlavumSmokingHumansBiomarkersMaleFemaleMiddle AgedHypertrophyInterleukin-6Tumor Necrosis Factor-alphaAdultInterleukin-1betaInflammationSmokersROC Curvealpha 1-AntitrypsinOxidative StressAged

Substanzen

BiomarkersInterleukin-6Tumor Necrosis Factor-alphaInterleukin-1betaalpha 1-Antitrypsin

Autor:innen und Institutionen

  • Neurosurgery Clınıc, Health Sciences University Haydarpaşa Training and Research Hospital, Istanbul, Turkey.
  • Department of Medical Biochemistry, Hamidiye Faculty of Medicine, University of Health Sciences Turkey, Istanbul, Turkey.
  • Department of Medical Biochemistry, Haydarpaşa Numune Health Application and Research Center, University of Health Sciences Turkey, Istanbul, Turkey.
  • Department of Medical Biochemistry, Hamidiye Institute of Health Sciences, University of Health Sciences Turkey, Istanbul, Turkey.
  • Neurosurgery Clınıc, Üsküdar State Hospital, Istanbul, Turkey.

ORCID-Profile: Eray Metin Güler

Zitieren

APA

Çetin, E., Başgül Sagiri, D., Kahraman Özlü, E. B., Akar, E., Güler, E. M., Kocaoğlu, S., Beyaztaş, H., & Demir, E. (2025). Inflammatory Biomarkers in Smokers: Implications for Ligamentum Flavum Hypertrophy. Medical Science Monitor. https://doi.org/10.12659/msm.947508

Vancouver

Çetin E, Başgül Sagiri D, Kahraman Özlü EB, Akar E, Güler EM, Kocaoğlu S, et al. Inflammatory Biomarkers in Smokers: Implications for Ligamentum Flavum Hypertrophy. Medical Science Monitor. 2025. doi:10.12659/msm.947508

BibTeX
@article{etin2025,
  author = {Çetin, Eyüp and Başgül Sagiri, Dilara and Kahraman Özlü, Eylem Burcu and Akar, Ezgi and Güler, Eray Metin and Kocaoğlu, Sarper and Beyaztaş, Hakan and Demir, Emine},
  title = {Inflammatory Biomarkers in Smokers: Implications for Ligamentum Flavum Hypertrophy},
  journal = {Medical Science Monitor},
  year = {2025},
  doi = {10.12659/msm.947508}
}
Kostenlos starten →